Taipan snake venom time has high sensitivity for lupus anticoagulants in non‐anticoagulated, triple positive antiphospholipid syndrome patients
International Journal of Laboratory Hematology · 2024
DOI: 10.1111/ijlh.14240 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von Gary W Moore und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Specialist Haemostasis Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Lupus Coagulation Inhibitor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Introduction
Dilute Russell's viper venom time (dRVVT) and activated partial thromboplastin time (APTT) are the mainstay assays in lupus anticoagulant (LA) detection yet they have limitations, particularly in relation to interferences and specificity. The recently validated Taipan snake venom time (TSVT) screening with ecarin time (ET) confirmatory assays overcome many of those limitations due to the innate specificity engendered from direct prothrombin activation, and insensitivity to the effects of vitamin K antagonists (VKA). The present study aimed to further evidence diagnostic utility of TSVT/ET by performing them in samples from 116 nonanticoagulated patients with established triple‐positive antiphospholipid syndrome (APS).
Methods
Samples were identified in three expert centres who performed dRVVT, APTT and solid phase antiphospholipid antibody assays with reagents from a variety of manufacturers. All samples additionally received TSVT/ET analysis using standardised reagents.
Results
Ninety seven of 116 (83.6%) were dRVVT‐ and APTT‐positive, 85/97 (87.6%) of which were TSVT/ET‐positive, 9/116 (7.8%) were dRVVT‐positive only, 6 of which were TSVT/ET‐positive, and 10/116 (8.6%) were APTT‐positive only, 5 of which were TSVT/ET‐positive. 96/116 TSVT/ET‐positivity returned a high sensitivity for LA of 82.8%. Low coefficients of determination revealed weak relationships between LA potency and anticardiolipin and anti‐β 2 ‐glycoprotein I antibody titres for all three LA assays.
Conclusions
TSVT/ET has high sensitivity for the clinically significant LA found in triple positive APS patients. TSVT/ET can establish multiple LA assay positivity in nonanticoagulated patients negative for one of dRVVT or APTT, and is the only assay pairing insensitive to VKAs, the recommended anticoagulation for APS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Specialist Haemostasis Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- Department of Natural Sciences, Faculty of Science and Technology, Middlesex University, London, UK.
- The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, UK.
- East and South East London NHS Pathology Partnership, Barts Health NHS Trust, London, UK.
- Synnovis Haemostasis and Thrombosis Laboratory, St. Thomas' Hospital, London, UK.
ORCID-Profile: Gary W Moore, Sean Platton, Nada Yartey, Eleanor Foxton, Danielle White, Stephen G MacDonald
Zitieren
APA
Moore, G. W., Platton, S., Yartey, N., Foxton, E., White, D., & MacDonald, S. G. (2024). Taipan snake venom time has high sensitivity for lupus anticoagulants in non‐anticoagulated, triple positive antiphospholipid syndrome patients. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14240
Vancouver
Moore GW, Platton S, Yartey N, Foxton E, White D, MacDonald SG. Taipan snake venom time has high sensitivity for lupus anticoagulants in non‐anticoagulated, triple positive antiphospholipid syndrome patients. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14240
BibTeX
@article{Moore2024,
author = {Moore, Gary W and Platton, Sean and Yartey, Nada and Foxton, Eleanor and White, Danielle and MacDonald, Stephen G},
title = {Taipan snake venom time has high sensitivity for lupus anticoagulants in non‐anticoagulated, triple positive antiphospholipid syndrome patients},
journal = {International Journal of Laboratory Hematology},
year = {2024},
doi = {10.1111/ijlh.14240}
}
EUVIMED